XML 19 R2.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash $ 18,896 $ 22,474
Accounts receivable 45 17
Inventory 278 111
Prepaid expenses, deposits, and other current assets 2,854 1,754
Total current assets 22,073 24,356
Fixed assets, net 1,334 1,592
Operating lease right-of-use assets 1,307 2,008
Intangible assets, net 1,424 3,445
Other assets 1,132 1,108
Total assets 27,270 32,509
Current liabilities:    
Accounts payable 1,146 1,056
Accrued expenses and other current liabilities 3,841 1,447
Operating lease liabilities, current portion 1,106 962
Senior Secured Convertible Note - at fair value 13,950
Due To: PAVmed Inc. - MSA Fee and operating expenses 9,339 4,960
Total current liabilities 29,382 8,425
Operating lease liabilities, less current portion 199 1,037
Total liabilities 29,581 9,462
Commitments and contingencies
Stockholders’ Equity:    
Preferred stock, $0.001 par value, 20,000,000 shares authorized; Series A and Series A-1 Convertible Preferred Stock, issued and outstanding 18,625 at December 31, 2023 and no shares issued and outstanding at December 31, 2022 18,625
Common stock, $0.001 par value, 200,000,000 shares authorized; 42,329,864 and 40,518,792 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively 42 41
Additional paid-in capital 129,763 121,081
Accumulated deficit (150,741) (98,075)
Total Stockholders’ Equity (Deficit) (2,311) 23,047
Total Liabilities and Stockholders’ Equity (Deficit) $ 27,270 $ 32,509